Chemplast Sanmar Ltd
It is a major manufacturer of Speciality Chemicals such as Specialty Paste PVC resin and Custom Manufactured Chemicals for agro-chemical, pharmaceutical and fine chemicals sector. The company also produces other chemicals such as Caustic Soda, Chlorochemicals, Hydrogen Peroxide, Refrigerant gas and Industrial Salt. The manufacturing facilities are located at Mettur, Berigai and Vedaranyam in Tamil Nadu and Karaikal in the Union Territory of Puducherry.
- Market Cap ₹ 7,415 Cr.
- Current Price ₹ 469
- High / Low ₹ 634 / 403
- Stock P/E
- Book Value ₹ 110
- Dividend Yield 0.00 %
- ROCE -2.06 %
- ROE -9.92 %
- Face Value ₹ 5.00
Pros
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE 250 SmallCap Index BSE 400 MidSmallCap Index Nifty MidSmallcap 400 BSE Commodities Nifty 500
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|
1,254 | 1,258 | 3,799 | 5,892 | 4,941 | 3,923 | 4,076 | |
969 | 1,011 | 3,171 | 4,695 | 4,473 | 3,897 | 3,912 | |
Operating Profit | 286 | 247 | 628 | 1,197 | 468 | 26 | 164 |
OPM % | 23% | 20% | 17% | 20% | 9% | 1% | 4% |
12 | 8 | 484 | 57 | -1 | 80 | 48 | |
Interest | 48 | 95 | 433 | 322 | 154 | 181 | 213 |
Depreciation | 56 | 87 | 131 | 137 | 142 | 151 | 174 |
Profit before tax | 193 | 72 | 547 | 796 | 172 | -226 | -175 |
Tax % | 39% | 36% | 25% | 18% | 11% | -30% | |
118 | 46 | 410 | 649 | 152 | -158 | -128 | |
EPS in Rs | 14.81 | 6.88 | 30.59 | 41.03 | 9.64 | -10.02 | -8.09 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 26% |
3 Years: | 1% |
TTM: | -6% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -462% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -6% |
1 Year: | -3% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 11% |
3 Years: | 16% |
Last Year: | -10% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|
Equity Capital | 67 | 67 | 67 | 79 | 79 | 79 | 79 |
Reserves | 2,433 | 1,845 | -417 | 1,626 | 1,779 | 1,622 | 1,660 |
253 | 1,289 | 2,127 | 882 | 1,019 | 1,548 | 1,525 | |
1,049 | 906 | 2,709 | 3,015 | 2,959 | 2,782 | 2,824 | |
Total Liabilities | 3,802 | 4,108 | 4,487 | 5,602 | 5,837 | 6,030 | 6,088 |
2,108 | 2,174 | 3,148 | 3,259 | 3,186 | 3,907 | 3,918 | |
CWIP | 117 | 8 | 25 | 34 | 402 | 190 | 247 |
Investments | 1,159 | 1,458 | 0 | 0 | 0 | 0 | 0 |
418 | 467 | 1,313 | 2,309 | 2,249 | 1,934 | 1,922 | |
Total Assets | 3,802 | 4,108 | 4,487 | 5,602 | 5,837 | 6,030 | 6,088 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
166 | 1,076 | 901 | 355 | -245 | ||
-438 | 2,152 | 108 | -217 | -524 | ||
298 | -3,017 | -313 | -27 | 382 | ||
Net Cash Flow | 26 | 211 | 696 | 111 | -387 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
Debtor Days | 19 | 14 | 7 | 12 | 11 | 18 |
Inventory Days | 183 | 158 | 70 | 70 | 73 | 77 |
Days Payable | 200 | 187 | 285 | 189 | 212 | 235 |
Cash Conversion Cycle | 2 | -16 | -208 | -108 | -128 | -141 |
Working Capital Days | -45 | -5 | -124 | -71 | -89 | -93 |
ROCE % | 6% | 21% | 50% | 15% | -2% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
18h - Earnings Conference Call scheduled for 10th February 2025.
-
Board Meeting Intimation for Inter Alia, To Consider, Approve And Take On Record The Unaudited Standalone As Well As Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended 31St December, 2024
30 Jan - Board meeting for approval of financial results.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 10 Jan
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2 Jan - Schedule of analyst meetings on January 7, 2025.
-
Announcement under Regulation 30 (LODR)-Credit Rating
27 Dec 2024 - CRISIL reaffirms ratings and enhances bank loan to Rs. 1801 crore.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from web
-
Financial Year 2020
from web
-
Financial Year 2019
from web
-
Financial Year 2018
from web
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
-
Financial Year 2010
from nse
Concalls
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT REC
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT REC
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Oct 2021TranscriptNotesPPT
History
Chemplast Sanmar Ltd was delisted in 2012 (at Mcap of 1,189 Cr.) following losses faced during the global financial crisis of 2008-09. It was relisted in 2021 at a Mcap of 8,553 Cr. [1]